DrugPatentWatch Database Preview

Emd Serono Company Profile

EMD SERONO has sixteen approved drugs.

There are nine US patents protecting EMD SERONO drugs.

There are two hundred and fifteen patent family members on EMD SERONO drugs in forty-three countries and sixty-one supplementary protection certificates in fifteen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597-002	Dec 1, 2003		DISCN	No	No		Start Trial				Start Trial
Emd Serono Inc	MAVENCLAD	cladribine	TABLET;ORAL	022561-001	Mar 29, 2019		RX	Yes	Yes	8,377,903	Start Trial				Start Trial
Emd Serono Inc	GLUCOPHAGE XR	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021202-001	Oct 13, 2000		DISCN	Yes	No		Start Trial				Start Trial
Emd Serono	SEROSTIM	somatropin	INJECTABLE;INJECTION	020604-001	Aug 23, 1996	BX	RX	No	No		Start Trial				Start Trial
Emd Serono	SAIZEN	somatropin	INJECTABLE;INJECTION	019764-002	Oct 8, 1996	BX	RX	Yes	No		Start Trial				Start Trial
Emd Serono	SEROSTIM	somatropin	INJECTABLE;INJECTION	020604-003	Jul 25, 1997		RX	No	No		Start Trial				Start Trial
Emd Serono Inc	CETROTIDE	cetrorelix	INJECTABLE;INJECTION	021197-002	Aug 11, 2000		DISCN	No	No	6,319,192	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emd Serono Inc	CETROTIDE	cetrorelix	INJECTABLE;INJECTION	021197-001	Aug 11, 2000	6,863,891	Start Trial
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-005	Mar 26, 2004	5,767,251	Start Trial
Emd Serono Inc	CETROTIDE	cetrorelix	INJECTABLE;INJECTION	021197-001	Aug 11, 2000	4,800,191	Start Trial
Emd Serono	NOVANTRONE	mitoxantrone hydrochloride	INJECTABLE;INJECTION	019297-001	Dec 23, 1987	4,278,689	Start Trial
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-004	Feb 28, 2001	5,767,251	Start Trial
Emd Serono	ZORBTIVE	somatropin recombinant	INJECTABLE;INJECTION	021597-004	Dec 1, 2003	5,288,703	Start Trial
Emd Serono	SEROSTIM	somatropin	INJECTABLE;INJECTION	020604-001	Aug 23, 1996	5,898,030	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1532149	C300569	Netherlands	Start Trial	PRODUCT NAME: LINAGLIPTINE, DESGEWENST IN DE VORM VAN EEN ZOUT, IN COMBINATIE MET METFORMINEHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/12/780/001-028 20120720
1827461	CR 2018 00010	Denmark	Start Trial	PRODUCT NAME: CLADRIBINE; REG. NO/DATE: EU/1/17/1212 20170824
0853945	SZ 6/2010	Austria	Start Trial	PRODUCT NAME: CORIFOLLITROPIN ALFA
1827461	18C1008	France	Start Trial	PRODUCT NAME: CLADRIBINE; REGISTRATION NO/DATE: EU/1/17/1212 20170824
0211894	96C0010	Belgium	Start Trial	PRODUCT NAME: FOLLITROPINE ALPHA; NAT. REGISTRATION NO/DATE: EU1/95/001/001 19951020; FIRST REGISTRATION: FI 11529 19940815
1412357	PA2008013,C1412357	Lithuania	Start Trial	PRODUCT NAME: SITAGLIPTINUM PHOSPHAS MONOHYDRICUS, METFORMINI HYDROCHLORIDUM; REGISTRATION NO/DATE: EU/1/08/455/001 - EU/1/08/455/014 20080716
1412357	C300357	Netherlands	Start Trial	PRODUCT NAME: SITAGLIPTINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZOUT, IN HET BIJZONDER HET MONOFOSFAAT, EN METFORMINE DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.